$117.91 -0.91 (%) Celgene Corp - NASDAQ

Jul. 7, 2015 | 02:15 PM

Partner Headlines

  1. Juno, Celgene Lead 5 Top Biotechs Nearing Buy Point

    IBD | Jul. 1, 2015 | 17:43PM EST
  2. What Is Beyond Vision-Loss Blockbuster For Regeneron?

    IBD | Jul. 1, 2015 | 16:12PM EST
  3. Juno up on $1 bil Celgene deal

    IBD | Jun. 30, 2015 | 18:54PM EST
  4. Mid-Day Market Update: Juno Therapeutics Jumps Following Announcement of 10-Year Collaboration With Celgene

    Benzinga | Jun. 30, 2015 | 13:21PM EST
  5. Juno Therapeutics CEO Weighs In On Celgene Partnership, T-Cell Innovations

    Benzinga | Jun. 30, 2015 | 13:21PM EST
  6. Juno-Celgene Deal Has Street Cautiously Optimistic

    IBD | Jun. 30, 2015 | 12:58PM EST
  7. Tuesday's Mid-Day Movers: Juno, Fitbit, Kandi Spike; Puerto Rico News Affecting Stocks

    Benzinga | Jun. 30, 2015 | 11:43AM EST
  8. Benzinga's Volume Movers

    Benzinga | Jun. 30, 2015 | 10:55AM EST
  9. Mid-Morning Market Update: Markets Rise; ConAgra Foods Plans To Exit Private Label Business

    Benzinga | Jun. 30, 2015 | 10:32AM EST
  10. Morning Market Gainers

    Benzinga | Jun. 30, 2015 | 09:54AM EST
  11. Stock Futures Take A Firm Bounce; Monster, Soufun Set To Rebound

    IBD | Jun. 30, 2015 | 09:08AM EST
  12. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 30, 2015 | 08:18AM EST
  13. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 30, 2015 | 08:06AM EST
  14. US Stock Futures Gain Ahead Of Economic Data

    Benzinga | Jun. 30, 2015 | 07:39AM EST
  15. Juno Therapeutics Signs $1 Billion Development Pact With Celgene

    Benzinga | Jun. 30, 2015 | 07:28AM EST
  16. Fast Money Picks For June 30

    Benzinga | Jun. 30, 2015 | 07:23AM EST
  17. Stocks To Watch For June 30, 2015

    Benzinga | Jun. 30, 2015 | 05:53AM EST
  18. Celgene, Juno Will Partner

    IBD | Jun. 29, 2015 | 19:02PM EST
  19. Celgene Places Big Bet On Juno's CAR-T Cell Therapy

    IBD | Jun. 29, 2015 | 18:13PM EST
  20. Celgene and Juno Announce Ten-Year Collaboration to Advance Potentially Groundbreaking Immunotherapies for Patients with Cancer and Autoimmune Diseases

    Benzinga | Jun. 29, 2015 | 16:07PM EST
  21. Epizyme Soars On Blood-Cancer Drug Data

    IBD | Jun. 22, 2015 | 14:50PM EST
  22. Health Care Stocks Power S&P 500 To Q1 Earnings Beat

    IBD | Jun. 19, 2015 | 17:16PM EST
  23. Fitbit Keeps Up Pace As Stocks Remain Near Session Highs

    IBD | Jun. 18, 2015 | 14:34PM EST
  24. Agios Price Target Cut On Cancer Drug Data Delay

    IBD | Jun. 15, 2015 | 11:38AM EST
  25. Agios/Celgene Leukemia Drug Scores, But Stocks Fall

    IBD | Jun. 12, 2015 | 16:53PM EST
  26. Big Biotech Stocks See Declining Short Interest

    Benzinga | Jun. 12, 2015 | 07:57AM EST
  27. Updated Results from MM-020/IFM 07-01 (First) Study of REVLIMID Presented at European Hematology Annual Congress

    Benzinga | Jun. 12, 2015 | 07:31AM EST
  28. Celgene Announces Will Offer Findings from Long-Term Post-Hoc Analysis of Pooled Data from PALACE Phase III Trial of Otezla at EULAR

    Benzinga | Jun. 9, 2015 | 18:02PM EST
  29. My Top 3 Pharma Stock Picks

    GuruFocus | Jun. 9, 2015 | 15:12PM EST
  30. Benzinga's M&A Chatter for Monday June 8, 2015

    Benzinga | Jun. 8, 2015 | 20:17PM EST
  31. 10 Reasons Why Growth Stocks Can Be Appropriate for Retired Investors

    GuruFocus | Jun. 4, 2015 | 16:37PM EST
  32. Meet 8 Hot Med Stocks Among IBD's Big Cap Leaders

    IBD | Jun. 3, 2015 | 08:01AM EST
  33. Celgene Offers New Data Which Will Be Presented at ELARAC

    Benzinga | Jun. 3, 2015 | 07:30AM EST
  34. Health Care Mutual Funds Top In May: Close Look At Two Winners

    IBD | Jun. 2, 2015 | 18:43PM EST
  35. ImmunoGen Surprises, PD-1 Drugs Under Scrutiny At ASCO

    IBD | Jun. 1, 2015 | 17:48PM EST
  36. 4 Stocks Rising On ASCO Cancer Drug News

    IBD | Jun. 1, 2015 | 12:34PM EST
  37. Research Can Be Key To Success For Tech Companies

    IBD | May. 29, 2015 | 16:53PM EST
  38. Big Pharma Companies Are Betting On Regenerative Medicine - Should You?

    GuruFocus | May. 26, 2015 | 13:35PM EST
  39. Move Over Chip Stocks: Here Are 5 Top Biotechs

    IBD | May. 20, 2015 | 09:34AM EST
  40. Move Aside, Chip Stocks, Biotechs Are Leaders Too

    IBD | May. 20, 2015 | 08:02AM EST
  41. China ETFs Power Ahead In 2015; Gold, Silver Get Shine Back

    IBD | May. 19, 2015 | 18:54PM EST
  42. Celgene, Lannett Lead Boisterous Day For Drugmakers

    IBD | May. 18, 2015 | 15:56PM EST
  43. Q1 Earnings Drive Industry Group Winners And Losers

    IBD | May. 8, 2015 | 18:59PM EST
  44. Celgene's Earnings Shine While Revenue Misses By An Inch In The First Quarter

    GuruFocus | May. 6, 2015 | 13:02PM EST
  45. Frothy China Or No, World Mutual Funds Topped In April

    IBD | May. 5, 2015 | 18:28PM EST
  46. Growth Names Pressured As IBD 50 Slumps 4% For Week

    IBD | May. 1, 2015 | 18:27PM EST
  47. Nasdaq Hits 5000 As Stocks Soar; JetBlue, Skyworks Take Flight

    IBD | May. 1, 2015 | 15:16PM EST
  48. Analysis of REVLIMID in Patients with Non-Del-5Q MDS Demonstrated Improved Health Related Quality of Life Measures

    Benzinga | May. 1, 2015 | 07:34AM EST
  49. Gilead's Strong Profit Tops Mixed Drug maker Reports

    IBD | Apr. 30, 2015 | 18:50PM EST
  50. Gilead EPS Soars Past Views

    IBD | Apr. 30, 2015 | 18:42PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!